Covid-19: CoronaVac vaccine to undergo evaluation, bottling assessment process before getting approval, says KJ


  • Nation
  • Saturday, 27 Feb 2021

PETALING JAYA: Part of the regulatory process for the CoronaVac vaccine’s approval also involves assessing how the vaccines will be bottled by Pharmaniaga, says Khairy Jamaluddin.

The Science, Technology and Innovation Minister said this when explaining why the first batch of CoronaVac vaccines was being brought to Malaysia before it had gotten approval by the National Pharmaceutical Regulatory Agency (NPRA).

“This is a bulk delivery of the vaccine, this is not the finished product. This is different from vaccines that enter the country in the form of vials.

“The vaccines that we have received today are in bulk and will be sent to the Pharmaniaga plant in Puchong where the regulatory approval process will start, ” he said during a press conference at the Kuala Lumpur International Airport after the first batch of the vaccines arrived on Saturday (Feb 27).

He explained that there are two approval processes involved, which are evaluation of the actual vaccine itself and the bottling process by Pharmaniaga.

“Many are asking why we are receiving vaccines that have yet to obtain approval by the regulatory agency?

“This is because the regulatory process involves assessing how the vaccine will be manufactured or bottled by Pharmaniaga, after which the vaccine can be approved.

“Yes, the CoronaVac is still being evaluated by NPRA, but for us to give approval for Pharmaniaga to conduct the fill-and-finish process, NPRA has to also assess Pharmaniaga’s processes as well and that cannot be done if we don’t have the vaccine.

“They have to study the stability report and the manufacturing processes of Pharmaniaga, then only NPRA can conduct assessment and recommendation for approval, ” he said.

He compared this to other countries such as Singapore that have tight regulatory controls and who have already received the vaccines as a finished product.

He added that should the vaccine be approved, Pharmaniaga is expected to produce two million doses every month.

Earlier Saturday, the vaccines touched down at KLIA at 8.55am on flight MH319, which was operated by MASKargo.

Developed by Sinovac Life Sciences Co Ltd, the vaccines had journeyed from the plant in Beijing, China and arrived in bulk totalling 200 litres.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In Nation

Stay united and prioritise the nation, says Nga
Appointment of Ahmad Zahid as DPM a betrayal of Pakatan voters, says Bersatu leader
Khairy congratulates newly-appointed successor, hopes she will uphold excellent public health system
I am honoured to be part of unity govt under Anwar, says Ewon on new ministerial appt
Cuepacs, MEF say Cabinet line-up possesses credibility, ability to work hard
Improve laws and women’s rights, says group
Sabah housewife loses over RM500,000 in love scam
Being appointed DPM a recognition for GPS, Borneo bloc, says Fadillah
Khaled helms Higher Education Ministry for a second time
Anwar hopes to restore economic confidence through new approaches in Finance Ministry

Others Also Read